Kasabach-merritt phenomenon: A report of 11 cases from a single institution

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 7, 2013, Pages 554-558

  Yasui, Naoko ^a   Koh, Katsuyoshi ^a   Kato, Motohiro ^a   Park, Myoung Ja ^a   Tomizawa, Daisuke ^a   Oshima, Koichi ^a   Uchisaka, Naoki ^a   Gocho, Yoshihiro ^a   Arakawa, Ayumu ^a   Seki, Masafumi ^a   Oguma, Eiji ^b   Kishimoto, Hiroshi ^c   Watanabe, Shoji ^a   Kikuchi, Akira ^a   Hanada, Ryoji ^a  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b Departments of Radiology   (Japan)

^c Departments of Pathology   (Japan)

Author keywords

chemotherapy; Kasabach Merritt phenomenon; vascular tumor

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ANTIHYPERTENSIVE AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; METHYLPREDNISOLONE; NAFAMSTAT MESILATE; PIRARUBICIN; PREDNISOLONE; PROPRANOLOL; STEROID; VINCRISTINE;

ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONSTIPATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FEMALE; GROWTH RETARDATION; HEMORRHAGIC CYSTITIS; HUMAN; HYDRONEPHROSIS; HYPERTENSION; INFANT; KASABACH MERRITT SYNDROME; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY DIAGNOSIS; LOSS OF APPETITE; MALE; NEUTROPENIA; OBSTRUCTIVE JAUNDICE; OSTEOPOROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RENAL INFILTRATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION;

COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KASABACH-MERRITT SYNDROME; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84885183076     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318281558e     Document Type: Article

References (19)

1. Esterly NB. Kasabach-Merritt syndrome in infants. J Am Acad Dermatol. 1983;8:504-513.
2. Enjolras O, Wassaf M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr. 1997;130:631-640.
3. Deb G, Jenker A, De Sio L, et al. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: successful treatment with a-2a interferon. Med Pediatr Oncol. 1997;28:358-361.
4. Mitsuhashi N, Furuta M, Sakurai H, et al. Outcome of radiation therapy for patients with Kasabach-Merritt syndrome. Int J Radiat Oncol Biol Phys. 1997;39:467-473.
5. Hermans DJ, Beynum IM, van der Vijver RJ, et al. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. J Pediatr Hematol Oncol. 2011;33:e171-e173.
6. Rodriguez V, Lee A, Witman PM, et al. Kasabach-Merritt phenomenon: case series and retrospective review of the mayo clinic experience. J Pediatr Hematol Oncol. 2009;31: 522-526.
7. Hauer J, Graubner U, Konstantopoulos N, et al. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer. 2007;49:852-854.
8. Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002;24:459-462.
9. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112:851-862.
10. Deb G, Jenker A, De Sio L, et al. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with a-2A interferon. Med Pediatr Oncol. 1997;28:358-361.
11. Sarkar M, Mulliken JB, Kozakewich HP, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100:1377-1386.
12. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998;132:527-530.
13. Hu B, Lachman R, Phillips J, et al. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. J Pediatr Hematol Oncol. 1998;20:567-569.
14. Blei F, Karp N, Rosfsky N, et al. Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. Pediatr Hematol Oncol. 1998;15:295-305.
15. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128:e259-e266.
16. Arunachalam P, Kumar VR, Swathi D. Kasabach-Merritt syndrome with large cutaneous vascular tumors. J Indian Assoc Pediatr Surg. 2012;17:33-36.
17. Lyons LL, North PE, Mac-Moune Lai F, et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 2004;28:559-568.
18. Kim DW, Chung JH, Ahn SH, et al. Laryngeal kaposiform hemangioendothelioma: case report and literature review. Auris Nasus Larynx. 2009;37:258-262.
19. Ryan C, Price V, John P, et al. Kasabach-Merritt phenomenon: a single centre experience. Eur J Haematol. 2009;84:97-104.